Siegrist Claire-Anne
Centre de vaccinologie et d'immunologie néonatale, HUG et Faculté de médecine, 1211 Genève 14.
Rev Med Suisse. 2010 Jan 13;6(231):67-70.
This manuscript reviews the main vaccine safety concerns that have limited the confidence of the population vis-a-vis influenza A(H1N1) vaccines and disturbed health professionals: A hasty development process? Excessively strong adjuvants? Notoriously toxic substances such as squalene and mercury salts? High risks of Guillain-Barre syndrome or auto-immune diseases? Deaths and other severe problems following immunization? Providing the available information, this manuscript asks whether a high-quality scientific communication would have reassured health professionals, and thus the population. The huge number of questions sent by professionals to InfoVac experts (www.infovac.ch), and the expressed gratitude, allows for some hope.
本手稿回顾了主要的疫苗安全问题，这些问题削弱了公众对甲型H1N1流感疫苗的信心，并困扰着卫生专业人员：研发过程仓促？佐剂过强？诸如角鲨烯和汞盐等臭名昭著的有毒物质？格林-巴利综合征或自身免疫性疾病的高风险？免疫接种后的死亡及其他严重问题？基于现有信息，本手稿探讨了高质量的科学传播是否能让卫生专业人员，进而让公众安心。专业人员向InfoVac专家（www.infovac.ch）提出的大量问题以及所表达的感激之情，带来了一些希望。
